ACKNOWLEDGEMENTS
J. Wanger: Pharmaceutical Research Associates, Inc., Lenexa,
KS, USA; J.L. Clausen: University of California, San Diego, CA,
USA; A. Coates: Hospital for Sick Children, Toronto, ON,
Canada; O.F. Pedersen: University of Aarhus, Aarhus,
Denmark; V. Brusasco: Universita
`
degli Studi di Genova,
Genova, Italy; F. Burgos: Hospital Clinic Villarroel, Barcelona,
Spain; R. Casaburi: Harbor UCLA Medical Center, Torrance,
CA, USA; R. Crapo and R. Jensen: LDS Hospital, Salt Lake City,
UT, USA; P. Enright: 4460 E Ina Rd, Tucson, AZ, USA; C.P.M.
van der Grinten: University Hospital of Maastricht, Maastricht,
the Netherlands; P. Gustafsson: Queen Silvias Children’s
Hospital,Gothenburg,Sweden;J.Hankinson:Hankinson
Consulting, Inc., Valdosta, GA, USA; D.C. Johnson:
Massachusetts General Hospital and Harvard Medical School,
Boston, MA, USA; N. MacIntyre: Duke University Medical
Center, Durham, NC, USA; R. McKay: Occupational Medicine,
Cincinnati, OH, USA; M.R. Miller: University Hospital
Birmingham NHS Trust, Birmingham, UK; D. Navajas:
Universitat de Barcelona – IDIBAPS, Barcelona, Spain; R.
Pellegrino: Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy;
G. Viegi: CNR Institute of Clinical Physiology, Pisa, Italy.
The original ATS/NHLBI Workshop participants (and their
affiliations at the time when the workshop was convened)
were as follows: E. Bancalari (University of Miami, Miami, FL,
USA); R.A. Brown (Massachusetts General Hospital, Boston,
MA, USA); J.L. Clausen (University of California, San Diego,
CA, USA); A.L. Coates (Hospital for Sick Children, Toronto,
Canada); R. Crapo (LDS Hospital, Salt Lake City, UT, USA); P.
Enright (University of Arizona, Tucson, AZ, USA); C. Gaultier
(Hopital Robert Debre, Paris, France); J. Hankinson (NIOSH,
Morgantown, WV, USA); R.L. Johnson Jr (University of Texas,
Dallas, TX, USA); D. Leith (Kansas State University,
Manhattan, KS, USA); C.J.L. Newth (Children’s Hospital, Los
Angeles, CA, USA); R. Peslin (Vandoeuvre Les Nancy, France);
P.H. Quanjer (Leiden University, Leiden, The Netherlands); D.
Rodenstein (Cliniques St. Luc, Brussels, Belgium); J. Stocks
(Institute of Child Health, London, UK); and J-C. Yernault{
(Hospital Erasme, Brussels, Belgium).
REFERENCES
1 Pellegrino R, Viegi G, Enright P, et al. Interpretative
strategies for lung function testing. Eur Respir J 2005; (In
press).
2 Clausen JL, Coates AL, Quanjer PH. Measurement of lung
volumes in humans: reviews and recommendations from
an ATS/ERS workshop. Eur Respir J 1997; 10: 1205–1206.
3 Stocks J, Quanjer PH. Reference values for residual
volume, functional residual capacity and total lung
capacity. ATS Workshop on Lung Volume Measure-
ments. Official Statement of The European Respiratory
Society. Eur Respir J 1995; 8: 492–506.
4 Clausen JL. Measurement of absolute lung volumes by
imaging techniques. Eur Respir J 1997; 10: 2427–2431.
5 Clausen JL. Lung volume equipment and infection control.
Eur Respir J 1997; 10: 1928–1932.
6 Leith DE, Brown R. Human lung volumes and the
mechanisms that set them. Eur Respir J 1999; 13: 468–472.
7 Hankinson JL, Stocks J, Peslin R. Reproducibility of lung
volume measurements. Eur Respir J 1997; 11: 787–790.
8 Bancalari E, Clausen JL. Pathophysiology of changes in
absolute lung volumes. Eur Respir J 1998; 12: 248–258.
9 Brown R, Enright P, Leith D. Multiple-breath helium
dilution measurements of lung volumes in adults. Eur
Respir J 1998; 11: 246–255.
10 Gaultier C, Crapo RO. Effects of nutrition, growth
hormone disturbances, training, altitude, and sleep on
lung volumes. Eur Respir J 1997; 10: 2913–2919.
11 Coates AL, Peslin R, Rodenstein D, Stocks J. Measurement
of lung volumes by plethysmography. Eur Respir J 1997; 10:
1415–1427.
12 Newth CJ, Enright P, Johnson RL Jr. Multiple breath
nitrogen washout techniques: including measurements
with patients on ventilators. Eur Respir J 1997; 10:
2174–2185.
13 NHLBI workshop. Consensus statement on measurement
of lung volumes in humans. www.thoracic.org/adobe/
lungvolume.pdf. Date last updated: 30 December 2003.
Date last accessed: 19 July 2005.
14 ACCP/ATS Joint Committee. Pulmonary terms and
symbols. Chest 1975; 67: 583–593.
15 Quanjer PH, Tammeling GJ, Cotes JE, et al. Symbols,
abbreviations, and units. Eur Respir J 1993; 6: Suppl. 16,
S85–S100.
16 Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF,
Peslin R, Yernault JC. Lung volumes and forced ventilatory
flows. Report Working Party, Standardization of Lung
Function Tests, European Community for Steel and Coal
and European Respiratory Society. Eur Respir J 1993; 6:
Suppl. 16, 5–40.
17 Quanjer PH, Sly PD, Stocks J. Respiratory function
measurements in infants: symbols, abbreviations and
units. Eur Respir J 1995; 8: 1039–1056.
18 Quanjer PH, Sly PD, Stocks J. Lung volumes and
ventilatory flows. Report Working Party, Standardization
of Lung Function Tests, European Community for Steel
and Coal and European Respiratory Society. Pediatr
Pulmonol 1997; 24: 2–11.
19 Miller MR, Crapo R, Hankinson J, et al. General considera-
tions for lung function testing. Eur Respir J 2005; 26:
153–162.
STPD Standard temperature (273 K, 0
˚
C), pressure (101.3 kPa,
760 mmHg) and dry
TB Tuberculosis
TGV (or V
TG) Thoracic gas volume
t
I Time taken for inspiration
TLC Total lung capacity
Tr Tracer gas
t
tot Total time of respiratory cycle
TV (or VT) Tidal volume
V
A Alveolar volume
V
A,eff Effective alveolar volume
VC Vital capacity
V
c Pulmonary capillary blood volume
V
D Dead space volume
V
I Inspired volume
V
S Volume of the expired sample gas
mg Micrograms
TABLE 1
(Continued)
J. WANGER ET AL. STANDARDISATION OF LUNG VOLUME MEASUREMENT
c
EUROPEAN RESPIRATORY JOURNAL VOLUME 26 NUMBER 3 521